TerrAscend (TSNDF) Cash & Equivalents (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Cash & Equivalents of $110000.0 for Q1 2026, down 99.62% year-over-year from $29.2 million in Q1 2025, and little changed quarter-over-quarter from $110000.0 in Q4 2025.
TerrAscend (TSNDF) Cash & Equivalents (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Cash & Equivalents for 6 consecutive years, with $110000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Equivalents fell 99.62% year-over-year to $110000.0; the TTM figure through Mar 2026 stood at $110000.0 (down 99.62% YoY), while the FY2025 annual figure was $110000.0, down 81.85% from the prior year.
- Cash & Equivalents steadied at $110000.0 in Q1 2026 per TSNDF's latest filing, from $110000.0 in the prior quarter.
- Across five years, Cash & Equivalents topped out at $88.4 million in Q1 2022 and bottomed at $110000.0 in Q4 2025.
- Historically, Cash & Equivalents has averaged $19.3 million across 5 years, with a median of $22.2 million in 2023.
- Annual changes were most pronounced in 2023 — Cash & Equivalents jumped 4679.34% — and 2026, when it slumped 99.62%.
- TerrAscend's Cash & Equivalents stood at $26.2 million in 2022, then fell by 14.97% to $22.2 million in 2023, then slumped by 97.28% to $606000.0 in 2024, then slumped by 81.85% to $110000.0 in 2025, then changed by 0.0% to $110000.0 in 2026.
- Business Quant data shows TSNDF's Cash & Equivalents at $110000.0 in Q1 2026, $110000.0 in Q4 2025, and $36.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 164.00 Mn |
| 10 | TerrAscend | 187.35 Mn | 145.23 Mn | 36.25 Mn | 42.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.03 Mn |
| Mar 31, 2026 | 110,000.00 |
| Dec 31, 2025 | 110,000.00 |
| Sep 30, 2025 | 36.52 Mn |
| Jun 30, 2025 | 26.67 Mn |
| Mar 31, 2025 | 29.25 Mn |
| Dec 31, 2024 | 606,000.00 |
| Sep 30, 2024 | 26.64 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Mar 31, 2024 | 3.11 Mn |
| Dec 31, 2023 | 22.24 Mn |
| Sep 30, 2023 | 606,000.00 |
| Jun 30, 2023 | 28.92 Mn |
| Mar 31, 2023 | 606,000.00 |
| Dec 31, 2022 | 26.16 Mn |
| Sep 30, 2022 | 34.29 Mn |
| Jun 30, 2022 | 605,000.00 |
| Mar 31, 2022 | 88.41 Mn |
| Dec 31, 2021 | 79.64 Mn |